Nutriband Inc Net Assets
Nutriband Inc net assets. Based on the latest financial reports, Nutriband Inc (NTRB) has net assets worth $5.33 Million USD as of July 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.29 Million) and total liabilities ($964.36K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Nutriband Inc growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.33 Million |
| % of Total Assets | 84.68% |
| Annual Growth Rate | N/A |
| 5-Year Change | -43.68% |
| 10-Year Change | 28804.27% |
| Growth Volatility | 1295.76 |
Net Assets of Nutriband Inc (2016–2026)
Net assets of Nutriband Inc from 2016 to 2026. This chart illustrates how Nutriband Inc's net assets have evolved over time, based on quarterly financial data. See Nutriband Inc net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Nutriband Inc (2016–2026)
The table below shows the annual net assets of Nutriband Inc from 2016 to 2026. For live market cap and overall valuation, see NTRB market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2026-01-31 | $6.68 Million | +3.90% |
| 2025-01-31 | $6.43 Million | -0.14% |
| 2024-01-31 | $6.44 Million | -24.90% |
| 2023-01-31 | $8.57 Million | -27.71% |
| 2022-01-31 | $11.86 Million | +66.75% |
| 2021-01-31 | $7.11 Million | +3953.94% |
| 2020-01-31 | $175.43K | -92.70% |
| 2019-01-31 | $2.40 Million | +1878.97% |
| 2018-01-31 | $121.51K | +425.80% |
| 2017-01-31 | $23.11K | +301.47% |
| 2016-01-31 | $-11.47K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nutriband Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4666606400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Nutriband Inc Net Assets Breakdown (January 2026)
Nutriband Inc net assets breakdown by equity component as of January 2026.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $12.16K | 0.18% |
| Other Comprehensive Income | $-304.00 | 0.00% |
| Other Components | $53.36 Million | 798.86% |
| Total Equity | $6.68 Million | 100.00% |
Nutriband Inc Competitors by Market Cap
The table below lists competitors of Nutriband Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EverFocus Electronics Corp
TW:5484
|
$70.50 Million |
|
Pioneer Credit Ltd
AU:PNC
|
$70.51 Million |
|
Se Gyung Hi Tech Co.Ltd
KQ:148150
|
$70.60 Million |
|
Airship AI Holdings Inc
NASDAQ:AISP
|
$70.60 Million |
|
Real Estate & E-Commerce Split Corp
TO:RS
|
$70.48 Million |
|
Anterogen.Co.Ltd
KQ:065660
|
$70.45 Million |
|
AGFA Gevaert NV
BR:AGFB
|
$70.41 Million |
|
Aniplus Inc
KQ:310200
|
$70.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nutriband Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 6,429,000 to 6,679,488, a change of 250,488 (3.9%).
- Net loss of 8,229,632 reduced equity.
- New share issuances of 5,305,503 increased equity.
- Other factors increased equity by 3,174,617.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-8.23 Million | -123.21% |
| Share Issuances | $5.31 Million | +79.43% |
| Other Changes | $3.17 Million | +47.53% |
| Total Change | $- | 3.90% |
Book Value vs Market Value Analysis
This analysis compares Nutriband Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 10.96x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-01-31 | $0.00 | $6.29 | x |
| 2017-01-31 | $0.00 | $6.29 | x |
| 2018-01-31 | $0.02 | $6.29 | x |
| 2019-01-31 | $0.39 | $6.29 | x |
| 2020-01-31 | $0.03 | $6.29 | x |
| 2021-01-31 | $1.06 | $6.29 | x |
| 2022-01-31 | $1.49 | $6.29 | x |
| 2023-01-31 | $1.01 | $6.29 | x |
| 2024-01-31 | $0.81 | $6.29 | x |
| 2025-01-31 | $0.61 | $6.29 | x |
| 2026-01-31 | $0.57 | $6.29 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nutriband Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -123.21%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -404.08%
- • Asset Turnover: 0.27x
- • Equity Multiplier: 1.13x
- Recent ROE (-123.21%) is above the historical average (-466.28%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $747.00 |
| 2017 | -654.55% | 0.00% | 0.00x | 1.63x | $-153.57K |
| 2018 | -2198.99% | 0.00% | 0.00x | 1.36x | $-2.68 Million |
| 2019 | -138.54% | -1358.11% | 0.09x | 1.17x | $-3.57 Million |
| 2020 | -1593.22% | -754.10% | 0.17x | 12.53x | $-2.81 Million |
| 2021 | -45.18% | -340.52% | 0.10x | 1.40x | $-3.92 Million |
| 2022 | -71.02% | -592.23% | 0.11x | 1.07x | $-9.61 Million |
| 2023 | -56.12% | -231.33% | 0.22x | 1.10x | $-5.67 Million |
| 2024 | -85.20% | -263.04% | 0.28x | 1.17x | $-6.13 Million |
| 2025 | -163.06% | -489.86% | 0.29x | 1.16x | $-11.13 Million |
| 2026 | -123.21% | -404.08% | 0.27x | 1.13x | $-8.90 Million |
Industry Comparison
This section compares Nutriband Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $154,916,114
- Average return on equity (ROE) among peers: -15.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nutriband Inc (NTRB) | $5.33 Million | 0.00% | 0.18x | $70.50 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $26.78 Million |
| Abcellera Biologics Inc (ABCL) | $1.06 Billion | -15.42% | 0.29x | $3.53 Billion |
| Abeona Therapeutics Inc (ABEO) | $-5.83 Million | 0.00% | 0.00x | $243.03 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $225.18 Million | -44.68% | 0.02x | $16.93 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $67.00 Million | -21.42% | 0.32x | $1.41 Billion |
| Arbutus Biopharma Corp (ABUS) | $40.92 Million | 73.18% | 0.29x | $768.65 Million |
| ABVC Biopharma Inc (ABVC) | $29.08K | -111.02% | 1.35x | $26.26 Million |
| Abivax SA American Depositary Shares (ABVX) | $34.02 Million | -17.32% | 0.13x | $7.74 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $182.13 Million | -20.84% | 0.04x | $3.54 Billion |
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company… Read more